Ondansetron
- Product NDC
- 51672-4091
- 11-digit product format
- 516724091
- Labeler code
- 51672
- Product ID
- 51672-4091_e10032ef-6d48-44cb-9b7f-9a338f35ca51
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ondansetron hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA077009
- Marketing category
- ANDA
- Marketing start
- 2007-11-30
- Substance
- ONDANSETRON HYDROCHLORIDE
- Active strength
- 4 mg/5mL
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON HYDROCHLORIDE | 4 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NMH84OZK2B |
| Rxcui | 312085 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-4091-3 | Ondansetron | 1 in 1 CARTON | SOLUTION | 1 | | 7 |
| 51672-4091-3 | Ondansetron | 50 mL in 1 BOTTLE | SOLUTION | 50 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-4091 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20190607_a95ca4f4-c4de-4822-9a08-209d10bf5136.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-4091-3 | 51672409103 | 1 BOTTLE in 1 CARTON (51672-4091-3) / 50 mL in 1 BOTTLE | 1 bottle | 2007-11-30 | 0000-00-00 | No | No | Current |